Early Intervention and Lifelong Treatment with GLP1 Receptor Agonist Liraglutide in a Wolfram Syndrome Rat Model with an Emphasis on Visual Neurodegeneration, Sensorineural Hearing Loss and Diabetic Phenotype
Toomas Jagomäe(University of Tartu), Mario Plaas(University of Tartu), Mihkel Plaas(Tartu University Hospital), Riin Reimets(University of Tartu), Eero Vasar(University of Tartu), Marko Pastak(Tartu University Hospital), Lies De Groef(Allen Institute for Brain Science), Miriam A. Hickey(University of Tartu), Allen Kaasik(University of Tartu), Lieve Moons(Allen Institute for Brain Science), Kaia Grete Kukker(University of Tartu), Anton Terasmaa(National Institute of Chemical Physics and Biophysics), Kadri Seppa(University of Tartu)
Cited by 30
Related Papers
Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
|Nature|1996|4.2k
Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions
|Nature Medicine|2001|1.7k
Role of tissue factor in embryonic blood vessel development
|Nature|1996|678
VEGF: A modifier of the del22q11 (DiGeorge) syndrome?
|Nature Medicine|2003|313
PGC-1α and PGC-1Β Regulate Mitochondrial Density in Neurons
|Journal of Biological Chemistry|2009|293